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Impaired Th2 Subset Development
in the Absence of CD4
Deborah J. Fowell,*² Jeanne Magram,§ model has emerged, wherein Th cell fate is determined
by the total number and/or quality of MHC class II±Christoph W. Turck,*³ Nigel Killeen,²
and Richard M. Locksley*² peptide±TCR interactions. Models in which stronger en-
gagements drive either Th1 (Pfeiffer et al., 1995) or Th2*Department of Medicine
²Department of Microbiology and Immunology (Thompson, 1995) development have been proposed,
but there is no clear understanding of how the strength³Howard Hughes Medical Institute
University of California, San Francisco of signal is regulated and detected by the T cell.
Earlier experiments demonstrated the presence ofSan Francisco, California 94143
§Department of Inflammation/Autoimmune fully functional Th1 cells in mice deficient in the CD4
coreceptor (Locksley et al., 1993; Rahemtulla et al.,Diseases
Hoffmann-La Roche, Inc. 1994). Because the CD4 coreceptor can directly affect
TCR stabilization with MHC class II±peptide complexesNutley, New Jersey 07110
(Doyle and Strominger, 1987; Fleury et al., 1991; Cam-
marota et al., 1992; Konig et al., 1992; Moebius et al.,
1993), we reanalyzed thecapacity for CD4-negativecellsSummary
to differentiate to Th2 effector cells in vivo and in vitro.
Unexpectedly, Th2 development was substantially com-Prior studies in CD4-deficient mice established the
promised in CD4-negative T cells from both CD4-defi-capacity of T helper (Th) lineage cells to mature into
cient mice and from TCR transgenic animals, and inTh1 cells. Unexpectedly, challenge of these mice with
CD41 T cells primed with MHC class II molecules unableNippostrongylus brasiliensis, a Th2-inducing stimulus,
to bind to CD4. Together, these data support a potentialfailed to result in the development of Th2 cells.
role for the coreceptor in modulating the signals thatAdditional studies were performed using CD41 or
mediate Th lineage commitment.CD42CD82 (double-negative) T cell receptor (TCR)
transgenic T cells reactive to LACK antigen of Leish-
mania major. Double-negative T cells were unable to Results
develop into Th2 cells in vivo, and, unlike CD41 T cells,
could not be primed for interleukin-4 production in Impaired Th2 Development in CD42/2 Mice Can
vitro. Similarly, CD41 TCR transgenic T cells primed Be Rescued by a Tailless CD4 Transgene
on antigen-presenting cells expressing mutant MHC Th cells are present in reduced numbers in CD42/2 mice
class II molecules unable to bind CD4 did not differen- (Sawada et al., 1994). Challenge with L. major or viruses
tiate into Th2 cells. These data suggest that interac- revealed that these cells were capable of Th1 develop-
tions between the TCR, MHC II±peptide complex and ment (Locksley et al., 1993; Rahemtulla et al., 1994),
CD4 may be involved in Th2 development. leaving open the questionof their capacity for Th2 differ-
entiation. To address this issue, CD42/2 mice were inoc-
ulated with Nippostrongylus brasiliensis, a potent in-Introduction
ducer of Th2-mediated immune responses (Urban et al.,
1992; Brown et al., 1996). When examined after 12 days,The mechanisms by which mature T helper (Th) cells
differentiate into discrete effector populations remain wild-type mice had expelled adult worms from the intes-
tines, and had generated robust Th2 immune responsesdiverse (Abbas et al., 1996). Roles for dose and route
of antigen administration (Kearney et al., 1994; Constant as assessed by marked elevations in serum immuno-
globulin (Ig) E and in numbers of interleukin (IL)-4±et al., 1995; Hosken et al., 1995; Guery et al., 1996),
types of antigen-presenting cells (Gajewski et al., 1991), secreting cells in the lung (Figure 1). In contrast, CD42/2
mice were unable to expel the adult worms, and hadactivation of discrete costimulatory pathways (Thomp-
son, 1995), underlying genetic predisposition (Gorham markedly abrogated IgE and IL-4 responses. Bycompar-
ison, and unlike CD42/2 mice, CD22/2 mice were capableet al., 1996; Schountz et al., 1996) and changes in the
cytokine milieu during the period of T cell priming (Seder of expelling worms and generated elevated IgE re-
sponses comparable to wild-type animals. Although theand Paul, 1994) have been demonstrated in various ex-
perimental systems. During Th differentiation, antigen- total number of IL-4±producing cells was reduced in
CD22/2 as compared to wild-type mice, the numbersspecific signals from the T cell receptor (TCR) are inter-
preted coordinately with signals from other molecules, were 6-fold greater than the numbers obtained in CD42/2
mice (Figure 1).such as cytokine or costimulatory receptors. Several
studies have suggested that these latter signals may CD4 can both stabilize MHC class II±TCR interactions
through extracellular interactionsor modulate intracellu-be particularly important in directing the differentiation
process. In other studies, the course of Th differentiation lar signals through its association with the tyrosine ki-
nase p56lck (Shaw et al., 1989). In an effort to determinehas been influenced by the choice of major histocompat-
ibility (MHC) molecules employed (Murray et al., 1989; whether the latter association was important for promot-
ing Th2 differentiation, experiments were performed us-Kumar et al., 1995; Schountz et al., 1996), or by the use
of altered peptide ligands for the TCR (Pfeiffer et al., ing CD42/2 mice that had been reconstituted with an
extracellular and transmembrane form of CD4 that1995). From such experiments, a ªstrength-of-signalº
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possibility that this reduced cellularity might contribute
to the observed Th2 defect, we reconstituted RAG-12/2
mice with increasing numbers of purified CD42/2 or
CD41 T cells. These chimeric mice were then challenged
with N. brasiliensis. As previously described in immu-
noincompetent mice (Urban et al., 1995), the nonrecon-
stituted RAG-12/2 mice failed to expel the worms. How-
ever, over a wide range of cells, CD41 T cells were
vastly superior to CD42/2 T cells in their capacity to
differentiate into Th2 effectors and to mediate expulsion
of the adult worms from the intestines (Figure 2). An
analysis of numbers of T cells in the reconstituted mice
at the time of death confirmed that reconstitution was
comparable among each of the groups of mice. Thus,
Th cells that do not express the CD4 molecule were
incapable of maturation into Th2 effectors in response
to this infectious challenge.
CD4-Negative, MHC Class II±Restricted, TCR
Transgenic T Cells Demonstrate Impaired
Th2 Development In Vivo
TCR transgenic mice facilitate the study of T cell re-
sponses because they are replete with large numbers
of antigen-specific T cells. However, such mice often
contain variable numbers of unusual CD42CD82 (dou-
ble-negative [DN]) cells that may emerge from the thy-
mus without passing through a CD41CD81 (double-pos-
itive) stage (Wilson et al., 1992; Capone et al., 1995;
Bruno et al.; 1996; Liu et al., 1996). We have observed
Figure 1. Impaired Th2 Development in CD42/2 Mice Infected with these cells in the periphery of mice expressing a
N. brasiliensis transgenic Vb4 Va8 TCR specific for the immunodomi-
Cohorts of 5 mice were inoculated with N. brasiliensis. After 12 days nant L. major LACK antigen (Mougneau et al., 1995)
the mice were killed and analyzed for (A) serum IgE by ELISA, (B) presented by I-Ad. After backcrossing onto the BALB/c
numbers of IL-4±producing cells by ELISPOT assay of dispersed
background, these mice contain large numbers of bothsuspensions of lung cells, and(C) numbersof wormsin the intestines
CD41 and CD42 (DN) TCR transgene (tg)1 peripheral Tby direct recovery and counting. WT, wild-type C57BL/6 mice;
CD42/2, mice with a disrupted CD4 gene; CD22/2, mice with a dis- cells (Figure 3). Since these two cell populations differ
rupted CD2 gene; CD42/2 Dcyt, mice with a disrupted CD4 gene in CD4 expression, we have compared their capacity to
reconstituted with a mouse CD4 transgene that lacked the cyto- differentiate into Th subsets using the well-character-
plasmic tail of CD4. Bars represent means and SEM. Results are ized L. major model for the in vivo development of Th1
shown from one of three representative experiments.
and Th2 effector cells (Reiner and Locksley, 1995).
Cohorts of BALB/c LACK TCR tg1 or tg2 littermate
controls were infected with L. major and the course oflacked the intracytoplasmic domain (Killeen and Litt-
man, 1993). After challenge with N. brasiliensis, these disease was monitored by measuring the size of the
local footpad lesions (Figure 4A). Although the TCR tg2mice developed Th2 responses that were not substan-
tively different than those in wild-type mice, suggesting littermates developed progressive infection that did not
differ from wild-type BALB/c mice, the TCR tg1 animalsthat functions mediated by the extracellular and/or
transmembrane domains of CD4 were sufficient to re- uniformly arrested their disease after 6±8 weeks. Fur-
ther, TCR tg2 mice had typical Th2 responses, as as-store type 2 immunity in vivo (Figure 1).
CD42/2 mice have reduced numbers of peripheral Th sessed by the presence of IL-4±producing cells in the
lymph nodes and elevated IgE levels in serum, whereascells as a consequence of diminished thymic output
(Killeen and Littman, 1993). In order to control for the the TCR tg1 mice developed Th1 responses to L. major,
Table 1. Host Response to L. major in LACK TCR Transgenic Mice
Cytokine-secreting cells/106 Log Parasite Titer
Serum IgE
Mice IL-4 IFNg (mg/ml) Footpad Spleen
Tg2 185 6 39 57 6 6.5 13.5 6 2.8 9.6 6 1.2 4.5 6 0.5
Tg1 27 6 9 123 6 49 0.6 6 0.1 2.5 6 0.5 2.5 6 0.5
Cohorts of 5 LACK TCR tg1 (Tg1) or tg2 littermates (Tg2) were infected with L. major. After 8 weeks, the numbers of cytokine-secreting cells
in the dispersed popliteal lymph node cells were assessed by ELISPOT assay; the total serum IgE levels were quantitated by ELISA; and the
log dilution of tissue homogenates from footpad and spleen that revealed motile promastigotes after culture in vitro was determined. Values
represent means and SEM from one of six comparable experiments.
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Figure 2. Reconstitution of Immunity to N.
brasiliensis in RAG-12/2 Mice
Groups of 5 RAG2/2 mice wereeither left non-
reconstituted or reconstituted by intravenous
injection with the designated numbers of
CD82, TCR ab1 T cells from CD42/2, or wild-
type donors and inoculated with larvae of N.
brasiliensis after 24 hr. After 12 days the mice
were killed and (A) the percentage worm ex-
pulsion (number of worms recovered com-
pared to the number in nonreconstituted
RAG2/2 mice, 3 100) and (B) the numbers of
IL-4±producing cells in the dispersed lung cell
populations as determined using an ELISPOT
assay.
as assessed by the presence of interferon-g (IFNg)± In contrast to CD41 T cells from the lymph nodes of
these infected mice, which produced large amounts ofproducing, but not IL-4±producing, cells in the draining
lymph nodes (Table 1). As anticipated, the presence of IL-4, the recovered DN T cells produced only IFNg (Fig-
ure 5B). Thus, these CD4-deficient Th cells were incapa-type 1 or type 2 immune responses correlated inversely
with the recovery of parasites from the lymph nodes ble of Th2 maturation even in a biologic milieu that sup-
ported Th2 development.and spleens of the mice (Table 1). Control of infection
was dependent on the conventional development of Although the precise lineage of the DN TCR tg1 T cells
remains unclear, these experiments clearly establishTh1-like effector cells, since crossing the mice to ani-
mals with disruption of the IL-12 p40 gene resulted in their capacity to mediate protective immunity using a
pathogen whose clearance is mediated by Th1 cellsuncontrollable leishmaniasis (Figure 4A) (Magram et al.,
1996; Mattner et al., 1996). (Reiner and Locksley, 1995). In agreement with prior
studies (Liu et al., 1996), we demonstrated that the DNTo establish whether the DN TCR tg1 cells were the
source of the aberrant IFNg production, cohorts of in- TCR tg1 T cells from these mice did not express endoge-
nous TCR a chains, as revealed by staining with a panelfected mice were treated three times weekly with mono-
clonal antibodies (MAbs) to CD4, such that CD4- of anti-Va TCR antibodies (data not shown), and had
failed to demethylate the CD8 gene, as revealed byexpressing TCR tg1 cells were depleted throughout the
course of infection. Although wild-type BALB/c mice Southern blotting after digesting purified DNA using
methylation-dependent endonucleases (Figure 6A). Af-repeatedly depleted of CD41 T cells were unable to
restrict progressive infection with L. major (Titus et al., ter digestion with BamHI and HpaII, peripheral CD41
TCR tg1 cells showed a demethylation pattern similar1987), the TCR tg1 mice readily controlled infection in a
manner not different from mice treated with an irrelevant to that in wild-type CD41 thymocytes, with bands at 5,
4.3, and 3.4 kb; DN TCR tg1 cells showed a major bandcontrol antibody (Figure 4B). Thus, these DN TCR tg1
cells differentiate to effector cells capable of protecting at 8 kb and a minor band at 5 kb, similar to the pattern
of wild-type DN thymocytes.animals from progressive disease.
Defective Th2 differentiation of the DN TCR tg1 T We also considered the possibility that these DN TCR
tg1 cells might utilize alternative TCR-coupled signalingcells might arise because of the absence of a regulatory
population of T cells in the TCR transgenic mice. Such
a regulatory role has been suggested for NK1.11CD41
T cells that mediated Th2 effector development in re-
sponse toanti-CD3 (Yoshimotoand Paul, 1994) and anti-
IgD (Yoshimoto et al., 1995). To examine this possibility,
purified BALB/c DN TCR tg1 T cells were passively
transferred into (BALB/c 3 BALB.K) F1 recipient mice
and infected with L. major. The F1 mice were used as
recipients to allow for the purification of the transferred
DN TCR tg1 T cells at the end of the experiment based
on their lack of expression of MHC class I Kk molecules.
Prior experiments demonstrated no alloreactivity be-
tween the BALB/c LACK-reactive tg1 T cells and cells
from theF1 mice (data not shown).The course of disease
in these recipient mice did not differ from nonreconstitu-
ted littermates; both cohorts of mice developed progres-
Figure 3. Peripheral T Cells in LACK TCR Transgenic Mice
sive infection typical of BALB animals (Figure 5A). After
Peripheral lymph node cells from a BALB/c LACK TCR transgenic8 weeks, the DN TCR tg1 T cells were purified from the
mouse demonstrate large numbers of Vb41 transgenic T cells in
mice using complement-depletion of MHC class I Kk- both CD41 and CD42 populations. Numbers represent percentages
bearing cells and immunofluorescent sorting. The cells of total lymphoid cells. Representative immunofluorescent analysis
from more than 100 transgenic mice.were then analyzed for their capacity to produce IL-4.
Immunity
562
Figure 5. Infection of BALB Mice Reconstituted with DN T Cells
from LACK TCR Transgenic Mice
(A) Groups of 5 BALB H2-Kk3d mice were either nonreconstituted
(BALB/c(d3k)) or intravenously reconstituted with 107 purified DN
LACK TCR tg1 T cells (BALB/c(d3k) 1 DN tg1(d3d)) and infected with
L. major along with 5 LACK TCRtg1 mice on the BALB/c background
Figure 4. Infection of LACK TCR Transgenic Mice (Tg1(d3d)) as a control. The course of disease was followed by mea-
(A) Groups of 5 BALB/c LACK TCR tg1 (Tg1) and BALB/c LACK TCR suring the size of the local footpad lesions.
tg2 littermates (Tg2), or the same mice crossed to BALB/c IL-12 (B) Dispersed lymph node cells were collected after 8 weeks of
p402/2 mice (IL-12 p402/2 Tg1 and Tg2, respectively), were infected infection from the designated groups of mice in (A) and used to
with 4 3 105 metacyclic promastigotes of L. major, and the course purify total T cells. DN TCR tg1 T cells were further purified from
of disease was followed by measuring the size of footpad lesions. the reconstituted mice by lysis of H2-Kk±bearing cells using anti-
Results are from one of three comparable experiments. H2-Kk MAb and complement. Cells (5 3 105/well) were incubated
(B) Groups of 5 BALB/c LACK TCR tg1 (Tg1), tg2 littermates (Tg2), with 1 mM LACK156±173 peptide and irradiated BALB/c T-depleted
and LACK TCR tg1 mice treated with anti-CD4 MAb (Tg1 1 anti- spleen cells (2.5 3 106/well) for 48 hr, and the supernatants were
CD4 MAb) were inoculated in the hind footpads with 4 3 105 promas- quantitated for IL-4 and IFNg by ELISA.
tigotes and the course of disease followed by measuring the size
of the local lesions. Mice treated with anti-CD4 received 500 mg
or DN TCR tg1 T cells were purified from LACK TCRGK1.5 antibody intraperitoneally on the day of infection and 250 mg
transgenic mice that had been crossed onto the BALB/cthree times weekly throughout the experiment. Mice treated with
TCR Ca2/2 background, thus removing contributionsanti-CD4 had less than 1.5% CD41 T cells at the end of the experi-
ment when lymph nodes and spleens were analyzed. from endogenous TCR a chains (Philpott et al., 1992).
The T cells were then cultured with irradiated antigen-
presenting cells that had been pulsed with varyingproteins, such as FceRgI and Syk, that might be prefer-
amounts of the cognate LACK156±173 peptide (Figure 7A,entially used by some DN ab and gd T cell populations,
left); proliferation of either cell type was peptide-depen-rather than CD3z and ZAP-70 used by conventional
dent and could be completely blocked by the inclusionCD41 T cells (Qian et al., 1993; Ohno et al., 1994; Shiue
of anti-MHC class II I-Ad MAb in the cultures (data notet al., 1995; Mallick-Wood et al., 1996). Immunoblotting
shown). Not unexpectedly, the CD41 T cells proliferatedof lysates from the DN TCR tg1 cells, as well as CD42/2
to a greater extent, particularly at higher peptide con-T cells fromCD4-deficient mice, however, revealed com-
centrations. Using peptide concentrations at whichparable amounts of ZAP-70 kinase as in CD41 TCR tg1
these two TCR tg1 populations proliferated comparably,cells, and no evidence for the use of Syk (Figure 6B).
theCD41 and DN TCR tg1 cells secreted markedly differ-
ent cytokines as assessed after a secondary stimulationDN TCR tg1 T Cells Cannot Be Primed by Antigen
with antigen (Figure 7A, middle and right); CD41 TCRfor IL-4 Production In Vitro
tg1 T cells produced both IL-4 and IFNg, whereas theWe next examined the capacity of the DN TCR tg1 T
cells to develop into Th2 effector cells in vitro. CD41 DN TCR tg1 T cells produced only IFNg.
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Figure 6. Analysis of DN LACK TCR Trans-
genic T Cells
(A) Analysis of methylation of the CD8 gene.
Immunofluorescent cell sorting was used to
obtain highly purified populations of DN thy-
mocytes from BALB/c mice (wt Thymus2/2),
CD41 thymocytes from BALB/c mice (wt Thy-
mus CD41), DN tg1 T cells from lymph nodes
of LACK TCR tg1 mice (Tg1 LNC2/2), and
CD41 tg1 T cells from lymph node cells of
LACK TCR tg1 mice (Tg1 LNC CD41). DNA
was isolated and digested with either BamHI
(B), BamHI followed by MspI (cuts both meth-
ylated and unmethylated DNA) (M), or BamHI
followed by HpaII (cuts only unmethylated
DNA) (H). After electrophoresis and transfer
to nitrocellulose, hybridization was per-
formed using a cDNA from the 59 end of the
murine CD8 gene. Size markers are shown at
left.
(B) TCR-associated kinases in normal CD41
and DN TCR tg1 T cells. Immunofluorescent
cell sorting was used to purify (.99%) BALB/
c CD41 TCR tg1 T cells (CD41 TCR tg1) and
DN TCR1, tg1 cells (DN TCR tg1) from LACK
TCR transgenic mice, or ab TCR1 CD42/2 T
cells (CD42/2). Complement-depletion was
used to produce B cell±enriched T-depleted
spleen cells (T-depleted SPN). Lanes were
blotted with MAb to ZAP-70, stripped, and
reprobed using antiserum to Syk. Molecular
weight markers are shown at left.
Cells were next cultured under the same conditions antigen presentation were transfected with either wild-
type I-Ad or I-Ad molecules that had been mutated towith optimal amounts of peptide with or without exoge-
nous IL-4 (Figure 7B). After 5 days, the T cells were abrogate interactions with CD4 (Konig et al., 1992).
Transfectants were matched for I-Ad expression andrestimulated in the absence of exogenous IL-4. Under
these conditions, the CD41 TCR tg1 cells from these used to present OVA323±339 peptide to purified OVA-spe-
cific CD41 TCR transgenic T cells in the presence orBALB/c mice produced readily detectable IL-4 in the
secondary assay, and the amounts recovered were absence of exogenous IL-4. After washing, cells were
restimulated with peptide presented by irradiated,greatly increased by the presence of exogenous IL-4
added to the primary stimulation conditions. In contrast, T-depleted, BALB/c spleen cells. Cells that had been
transfected with thewild-type I-Ad molecules were capa-the DN TCR tg1 cells did not produce IL-4 in the second-
ary reaction, even after the addition of exogenous IL-4. ble of priming IL-4 production from the responding CD41
T cells, particularly in the presence of exogenous IL-4These cells did respond to exogenous IL-4, however,
as demonstrated by the consistent decrease in the (Figure 8). In contrast, L cells transfected with the mu-
tated I-Ad molecules that were impaired in their capacityamounts of IFNg recovered in the secondary superna-
tants from IL-4±treated cells. Further, IL-4 could be pro- to bind CD4 were unable to support the development
of IL-4±producing T cells under the same conditions.duced by the DN TCR tg1 cells (as well as CD42/2 T
cells) after incubation with anti-TCR and anti-CD28 anti- Similar to the results with the LACK-reactive DN TCR
tg1 cells, the CD41 cells primed on the mutant I-Ad mole-bodies, although the levels of recovered IL-4 were ap-
proximately 2-fold less than from comparably treated cules in the presence of IL-4 produced lower amounts
of IFNg during the secondary stimulation.CD41 cells (D. J. F. and R. M. L., unpublished data).
Antigen-Presenting Cells That Express Mutated Discussion
MHC Class II Molecules Unable to Bind to CD4
Impair the Differentiation of Th2 Cells In Vitro The mechanisms that direct naive CD41 T cells to be-
come mature effector lymphocytes are crucial in de-The capacity of the tailless CD4 transgene to rescue Th2
lineage development in the N. brasiliensis experiments termining the outcome of immune responses to many
types of infectious and inflammatory challenges. Al-suggested that extracellular interactions of CD4, per-
haps with MHC class II (Doyle and Strominger, 1987; though key cytokines undoubtedly play a central role in
governing the differentiation of Th1 and Th2 effectorFleury et al., 1991; Cammarota et al., 1992; Konig et al.,
1992; Moebius et al., 1993) or the TCR (Vignali et al., cells from naive precursors (Seder and Paul, 1994; Ab-
bas et al., 1996), models have been proposed whereby1996), were sufficient to mediate the requirements for
Th2 lineage commitment in vivo. To assess the potential the strength of interaction mediated through the TCR
and MHC±peptide complex might directly affect lineagerole of CD4±MHC class II interactions in Th2 develop-
ment in vitro, L cells that were otherwise competent for commitment (Constant et al., 1995; Kumar et al., 1995;
Immunity
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Figure 7. Priming of DN T Cells for IL-4 Production In Vitro
(A) CD41 and DN LACK TCR tg1 cells were purified by immunofluorescent sorting and incubated using 5 3 105 cells/well with 0.04 mM
LACK156±173 peptide and irradiated T-depleted spleen cells (2.5 3 106/well). After 5 days, the cells were washed, counted and restimulated.
(Left) 2 3 105 cells/well in the presence of the designated concentrations of LACK156±173 peptide with irradiated T-depleted spleen cells (2.5 3
106/well) were analyzed for cell proliferation using [3H]thymidine incorporation after 72 hr. (Middle and right) Designated numbers of T cells
were incubated in the presence of 1 mM LACK156±173 peptide and irradiated T-depleted spleen cells (2.5 3 106/ well), and supernatants were
collected after 48 hr and analyzed for IL-4 (middle) or IFNg (right) using ELISA. Representative results from one of five comparable experiments.
(B) Highly purified CD41 or DN LACK TCR tg1 T cells were incubated as in (A) either in the absence (no IL-4) or presence of exogenous rIL-4
(100 ng/ml) (1IL-4 in 1o). After 5 days, cells were washed extensively and reincubated using 2 3 105 cells/well with 1 mM LACK156±173 peptide
and irradiated T-depleted spleen cells (2.5 3 106 cells/well). After an additional 48 hr incubation, the supernatants were collected and analyzed
for IL-4 and IFNg using ELISA.
Thompson, 1995). As demonstrated by the experiments worms from the intestines of immunocompetent mice
by 10±12 days (Urban et al., 1992; Urban et al., 1995).here, Th cells that did not express the CD4 coreceptor
were deficient in their capacity to differentiate into Th2 When infected with N. brasiliensis, however, CD42/2
mice displayed no evidence of the expected type 2 im-cells in response to antigen in vivo or in vitro. This defi-
ciency was evident using both CD4-negative cells from mune response, and this was functionally manifest as
an inability to expel the worms. The apparent Th2 defectCD4 gene±disrupted mice and the DN T cells that devel-
oped in MHC class II±restricted TCR transgenic mice. was not solely due to the decreased numbers of cells
that completed Th lineage development in the CD42/2The defect was observed in response to disparate chal-
lenges, including intestinal helminths and intracellular mice. This was shown by the inability of the CD42/2 T
cells to promote worm expulsion even after the transferprotozoa, confirming the inability of these cells to pro-
duce IL-4 under physiologically relevant circumstances of large numbers of cells to RAG-12/2 mice. Thus, the
results are consistent with a cell-intrinsic block to thein vivo. Further, the Th2 defect was also evident when
CD41 T cells were primed by antigen-presenting cells differentiation of Th2 cells when CD4 is lacking.
Studies of peripheral MHC class II±restricted T cellsthat expressed mutated MHC class II molecules that
were unable to bind to CD4. Taken together, the data in CD42/2 mice that express a human CD2 transgene
under control of the murine CD4 promoter suggestedsupport a model whereby the CD4 coreceptor can mod-
ulate Th subset lineage commitment. that these cells underwent normal thymic development
(Bendelac et al., 1994; Liu et al., 1996). However, ThPrior investigations in CD42/2 mice have established
that Th1 development to pathogens is unimpeded cells in CD42/2 mice may be positively selected in the
thymus only if they expresshigh avidityTCRs that enableamong the reduced numbers of cells that complete oth-
erwise normal MHC class II±dependent thymic selection selection in the absence of the coreceptor. It is possible
that this qualitative aspect of the Th repertoire affects(Locksley et al., 1993; Rahemtulla et al., 1994). N. bra-
siliensis infection invokes a highly CD4-dependent, type Th2 differentiation. We have addressed this possibility
by using MHC class II±restricted TCR transgenic mice2 immune response that mediates expulsion of the adult
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Figure 8. Priming of CD41 T Cells for IL-4
Production by Antigen-Presenting Cells That
Express Mutations That Abolish MHC Class
II Binding to CD4
OVA-specific CD41 TCRtg1 T cells were puri-
fied from DO11.10 mice and incubated with
transfected L cells that expressed either wild-
type I-Ad (wt I-Ad) or I-Ad mutated to abrogate
binding to CD4 (mutant I-Ad) in the presence
of 1.6 mM OVA323±339 peptide with (1IL-4 in 1o)
or without (no IL-4) 100 ng rIL-4. After 7 days,
T cells were washed and reincubated with
irradiated T-depleted spleen cells expressing
wild-type I-Ad with 0.6 mM OVA323±339 peptide.
Supernatants were collected after 48 hr and
quantitated forIL-4 (left) and IFNg (right) using
ELISA. Data represent one of two comparable
experiments.
and analyzing the differentiation of CD41 and CD42 tg1 the wild-type I-Ad molecules. Importantly, these experi-
ments indicated that lineage commitment had occurredT cells that expressed the same TCR. DN tg1 T cells
that develop in TCR transgenic mice may arise through during the priming phase, since wild-type I-Ad molecules
used in the secondary stimulation could not reconstitutean accelerated developmental process. Various studies
have suggested that coreceptor down-modulation on IL-4 production from CD41 T cells that had been primed
by peptides presented by the mutated MHC class IIthese cells may be a mechanism for escaping negative
selection (Kisielow et al., 1988; Sherman et al., 1992; molecules. Experiments with peptides corresponding
to this region in the b2 domain of I-Ad demonstratedJameson et al., 1994) or that this reflects abortive com-
mitment to the gd lineage(Bruno et al., 1996). Compelling preferential enhancement of IFNg and IL-2 production,
consistent with a modulating role for CD4±MHC classdata produced by the introduction of artificial V(D)J re-
combination substrates (Capone et al., 1995) supports II binding in the differentiation of effector Th subsets
(Shen et al., 1996). Taken together, the data accumu-the hypothesis that these cells prematurely exit the thy-
mus and populate the periphery as fully antigen-respon- lated in the three different systemsÐCD42/2 mice, DN
TCR tg1 T cells, and class II mutations that abolishsive T cells (Liu et al., 1996). The DN tg1 T cells from
the LACK-reactive TCR transgenic mice were reactive CD4 bindingÐsupport a potential role for CD4 in Th2
differentiation in vitro and in vivo.to thecognate peptide in vitro and mediated Th1-depen-
dent protective immune responses to a complex patho- Given that each of the model systems involved mu-
tated or aberrantly generated cells, it is reasonable togen in vivo. Th1 development of these DN cells, as has
been shown for CD41 cells, was dependent on IL-12 question whether the interactions delineated by these
experiments are functionally relevant to normal Th sub-(Magram et al., 1996; Mattner et al., 1996). Further analy-
sis indicated that DN TCR tg1 cells, in agreement with set differentiation. Studies of the CD4-MHCclass II inter-
acting surface have defined not only a major bindingprior studies (Liu et al., 1996), had not demethylated the
CD8 gene; however, like the CD41 TCR tg1 T cells, DN site in the b2 domain, but also a secondary site in the
a2 domain (Moebius et al., 1993; Konig et al., 1995;TCR tg1 cells expressed predominantly the ZAP-70 sig-
naling kinase rather than the related Syk kinase. The Huang et al., 1997). Based on structural analysis of CD4
and class II, these sites might not be accessible to thelatter finding shows that the DN TCR tg1 T cells do
not express a fundamentally different TCR-associated same MHC class II molecule, but rather might serve to
bridge different MHC complexes, thus facilitating thecomplex, such as that described for many conventional
DN ab and gd lymphocytes (Qian et al., 1993; Ohno et higher ordered oligomerization required for effective T
cell activation (Symer et al., 1992; Germain, 1993; Konigal., 1994; Shiue et al., 1995; Mallick-Wood et al., 1996).
Despite the unusal lineage of the DN tg1 T cells, the et al., 1995; Huang et al., 1997). The localization of the
binding site for CD8 on MHC class I is topographicallystriking finding was their inability to differentiate to func-
tional Th2 effector cells in vivo, thus mimicking the similar to that for CD4 on MHC class II (Cammarota et
al., 1992; Konig et al., 1992), and CD8 has been demon-phenotype of the CD42/2 Th lineage cells. Since the
LACK-reactive DN and CD41 tg1 T cells from Ca2/2 mice strated to lengthen substantially the dissociation rate
between the TCR and MHC class I±peptide complexesexpressed identical TCRs, the experiments suggested
a direct role for CD4 in the differential responses to IL- (Luescher et al., 1995; Garcia et al., 1996). Models sug-
gesting that higher-affinity or -avidity interactions might4±mediated Th2 priming. This was corroborated using
antigen-presenting cells that expressed mutant I-Ad be necessary for Th2 development have been proposed
and would be consistent with a role for CD4 in stabi-molecules with two point mutations in the b2 domain of
the MHC class II molecule, rendering it incapable of lizing the TCR±MHC complex to permit oligomerization
and the formation of supercomplexes. Unlike MHC classbinding to CD4 but leaving presentation of the OVA323±339
peptide unaffected (Konig et al., 1992). As shown here, I, the MHC class II peptide-binding groove can accom-
modate longer peptides that might protrude from thethe presentation of antigens by such mutants abrogated
the normal differentiation of CD41 Th2 cells that other- binding cleft and conceivably affect the interactions of
the CD4 coreceptor with either MHC or the TCR itselfwise occurred during priming with exogenous IL-4 using
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examined for motile promastigotes by inverted microscopy to deter-(Vignali et al., 1996). Impaired interactions of CD4 with
mine the tissue parasite burdens.the MHC complex could favor interactions of CD4 with
other molecules (Imai et al., 1995) that might modulate
T cell development. Solution of the TCR±MHC±peptide Isolation and Purity of Lymphocyte Populations
CD41 and DN TCR tg1 T cells from tg1 TCR Ca2/2 mice were isolatedstructure in association with the CD4 coreceptor will
from spleen and lymph node cells by antibody/complement-medi-undoubtedly contribute further to the remarkable under-
ated lysis followed by flow cytometric sorting. Briefly, single-cellstanding already accrued by analysis of the TCR±MHC±
suspensions were made by passing tissue through a 0.75 mm nylon
peptide complex (Garboczi et al., 1996; Garcia et al., mesh filter using a syringe plunger. Cells were washed twice,
1996), and suggest structural mechanisms by which the counted and depleted of B cells, MHC class II± and CD8-bearing
CD4 molecule might contribute to Th2 development un- cells using MAbs J11d, BP107,3.155 (all from American Type Culture
Collection; Rockville, MD), respectively, and low-toxicity rabbit andder the conditions of normal T cell activation.
guinea pig complement (Cedarlane; Ontario, Canada). The resulting
population (routinely 85%±90% TCR ab1 T cells) was labeled withExperimental Procedures
phycoerythrin-conjugated anti-CD4 and fluorescein isothiocyanate
(FITC)±conjugated anti-Vb4 MAbs and sorted on a flow cytometerMice
(FACS Star Plus, Becton Dickinson; Mountain View, CA) forFemale BALB/c, C57BL.6, and B10.D2 mice (Jackson Laboratories,
Vb41CD41 and Vb41CD42CD82 populations. The resulting cell pop-Bar Harbor, ME) were maintained in the pathogen-free Animal Care
ulations were more than 98% pure.Facility at the University of California, San Francisco. CD42/2 mice
CD42/2 and CD41 cells used for RAG-12/2 reconstitutions were(Killeen et al., 1993), CD42/2 mice rescued with a tailless murine
isolated by depletion of B cells, MHC class II1 and CD81 cells byCD4 transgene (Killeen and Littman, 1993), CD22/2 mice (Killeen et
complement-mediated lysis as described above. Purity of CD41al., 1992), RAG-12/2 mice (Mombaerts et al., 1992), and TCR Ca2/2
cells was routinely 85%±90% TCR ab1 CD41, while cells frommice (Philpott et al., 1992) were on the B6 background unless speci-
CD42/2 mice were 80% TCR ab1 CD42 as analyzed by flow cytome-fied otherwise. T cells from the DO11.10 TCR transgenic mice on the
try. Both populations were 98% CD82. The enriched populationsBALB/c background recognize a peptide comprising amino acids
were normalized for equivalent numbers of T cells prior to adoptive323±339 from chicken ovalbumin in the context of I-Ad (Murphy et
transfer.al., 1990). T cells from the LACK TCR transgenic mice on the BALB/c
DN TCR tg1 cells were purified from infected BALB H2-Kk3d micebackground (10 times backcrossed to BALB/c) recognize a peptide
by depletion of H2-Kk± and MHC class II±bearing cells using MAbscomprising amino acids 156±173 from the immunodominant LACK
16±1-N1 and BP107 (American Type Culture Collection), respec-antigen of L. major (Mougneau et al., 1995) in the context of I-Ad.
tively, and rabbit and guinea pig complement. The resulting popula-These mice express a Vb4 Va8 TCR derived from the murine
tion was more than 78% H2-Kd1k2Vb41.CD41 Th1 clone 9.1-2 (Scott et al., 1990; Reiner et al., 1993). The
CD41 DO11.10 T cells were isolated by depletion of B cells, MHCBALB/c LACK TCR transgenic mice were backcrossed 8 times to
class II± and CD8-bearing cells as described above. To avoid poten-BALB/c TCR Ca2/2 mice for use in designated experiments. The
tial effects of anti-CD4 MAb during the in vitro assays, the enrichedIL-12 p402/2 mice (Magram et al., 1996) were backcrossed 5 times
population was labeled with a combination of FITC-conjugated anti-onto the BALB/c background and then crossed into the LACK TCR
Thy 1.2 and phycoerythrin-conjugated anti-CD8 and anti-pan gd (alltransgenic line to establish LACK TCR tg1, IL-12 p402/2 BALB/c
PharMingen, San Diego, CA) and sorted using a flow cytometer formice.
Thy 1.21CD82gd2 T cells. The resulting population was more than
97% CD41, ab TCR1.
Parasites and Infections
Infective third-stage larvae of N. brasiliensis were isolated from the
feces of experimentally infected rats as described (Brown et al., Antigen-Presenting Cells
1996), washed extensively with saline, counted, and injected subcu- T-cell depleted spleen cells were prepared from BALB/c mice by
taneously at the base of the tail into designated cohorts of mice depletion of Thy 1.2±bearing cells using the J1j MAb (American Type
using 500 worms/mouse in 0.2 ml phosphate-buffered saline (PBS). Culture Collection) and complement prior to treatment of the cells
The mice were killed after 12 days and the numbers of adult worms with 3000 rad g-irradiation. The resultant cell preparations were
determined by direct visualization after opening the intestines with routinely more than 96% CD4- and CD8-negative.
an enterotome. The lungs were completely blanched with ice-cold L cells (kindly provided by R. Germain, National Institutes of
PBS, excised, minced into fine fragments, and dispersed into a Health, Bethesda, MD) transfected with I-Ad (designated 44/14.B5)
single-cell solution in PBS using a syringe plunger. Cells were or with I-Ad containing two alanine mutations at positons 137 and
passed through a 0.75 mm nylon mesh filter, washed twice, counted, 142 in the b2 domain (Konig et al., 1992) that abrogate CD4 binding
and adjusted to 107 cells/ml in cell culture medium (RPMI 1640 with (designated 47/1. B3) were maintained in Dulbecco's modified mini-
10% fetal calf serum (Hyclone, Logan, UT), 2 mM L-glutamine, 0.1 mal essential medium supplemented with 10% fetal calf serum, 2
mM sodium pyruvate, 100 U/ml each of penicillin and streptomycin, mM L-glutamine, 100 U/ml each of penicillin and streptomycin, and
and 50 mM 2-mercaptoethanol) for use in cytokine ELISPOT assays. the selecting drug 200 mg/ml G418 (GIBCO±BRL, Bethesda, MD).
Serum was prepared at the time of death for measurements of IgE Clones were established that expressed comparable levels of the
by enzyme-linked immunosorbent assay (ELISA). two I-Ad molecules as assessed by flow cytometric assay after label-
Designated cohorts of mice were inoculated in the hind footpads ing with FITC-conjugated anti-I-Ad MAbfor use in theseexperiments.
with 4 3 105 metacyclic promastigotes of L. major (strain WHOM/ The cells were cultured in the absence of G418 for 48 hr prior to
IR/-/173) maintained and purified as described (Reiner et al., 1994). their use in T cell priming assays.
The progression of disease was monitored weekly using a metric
caliper to measure the footpad lesions. Animals were killed at the
indicated times, usually 6±8 weeks, and the popliteal lymph nodes T Cell Reconstitutions
RAG-12/2 mice were reconstituted with CD41 or CD42/2 cells in 0.2were harvested for the evaluation of cell phenotypes and cytokine
determinations, the serum was collected for measurements of IgE, ml PBS by intravenous injection 24 hr prior to inoculation with N.
brasiliensis. 107 DN TCR tg1 T cells were transferred to BALB H2-and the footpads and spleens were collected for quantitation of the
tissue parasite burden. The footpads were washed in ethanol, rinsed Kk3d in 0.2 ml PBS by intravenous injection 24 hr prior to inoculation
with L. major. The transferred DN TCR tg1 T cells represented 1.5%in Hanks' balanced salt solution, and homogenized in 4 ml of
HOSMEM medium (Berens and Marr, 1978). The spleens were ho- of total lymphocytes in the peripheral lymph nodes draining the site
of infection after 8 weeks. No T cell reactivity was demonstratedmogenized in 5 ml of HOSMEM. Aliquots were serially diluted into
flat-bottom 96-well microtiter plates and incubated at 268C for 1 using the LACK-specific DN TCR tg1 T cells in mixed lymphocyte
reactions with (BALB/c 3 BALB.K) F1 H-2Kk±bearing cells.week for footpad tissues and 2 weeks for spleen. The wells were
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In Vitro T Cell Priming comments; R. L. Coffman (DNAX Research Institute, Palo Alto, CA),
R. Germain (National Institutes of Health, Bethesda, MD), and N.Primary cultures of TCR tg1 T cells (5 3 105 cells/well in 2 ml cell
culture medium) were performed in 24 well plates with 2.5 3 106 van Oers and A. Weiss (University of California, San Francisco, CA)
for critical reagents; S. Tonegawa (Massachusetts Institute of Tech-irradiated, T-depleted spleen cells as a source of antigen-presenting
cells and 0.04 mM LACK156±173 peptide. In some experiments 100 ng/ nology, Cambridge, MA), D. Loh (Washington University, St. Louis,
MO), and A. Hayday (Yale University, New Haven, CT) for transgenicml murine rIL-4 was added to the primary culture (kindly provided
by R. Coffman, DNAX Research Institute, Palo Alto, CA). After 5 mice; and E. Weider (Gladstone Institute for Virology, University of
California, San Francisco) for assistance with cell sorting. This workdays of primary culture, cells were collected, washed three times
and restimulated at 2 3 105 cells/well (unless otherwise stated) with was supported by grant AI-30663 from the National Institutes of
Health and an intramural grant from the Howard Hughes Medical2.5 3 106 T-depleted splenocytes and 1 mM LACK156±173 peptide in
96-well round bottomed plates. Supernatants from duplicate cul- Institute. D. J. F. is a Fellow of the Juvenile Diabetes Foundation
International. R. M. L. is a Burroughs Wellcome Fund Scholar intures were harvested after 48 hr for cytokine analysis by ELISA.
Proliferation was assessed by the incorporation of 1 mCi [3H]thymi- Molecular Parasitology.
dine over 18 hr after addition to 72 hr cultures.
Primary cultures of DO11.10 tg1 T cells (5 3 105 cells/well in 2 ml Received February 19, 1997; revised March 28, 1997.
cell culture medium) were performed in 24-well plates with 1.6 mM
OVA323±339 peptide and L cells transfected with MHC class II I-Ad or References
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